Replies to post #195670 on Biotech Values

[DewDiligence]

EXAS -45%—the same % as in yesterday’s AH trading. I plan to listen to the company’s CC shortly.

The share price is now at a level last seen before EXAS reported top-line data from the DeeP-C study in 2013.